key articles
Long-term outcomes of percutaneous radio frequency ablation of small renal mass
Sunday, 13 July 2008 - Levinson et al. (2008) presented long-term outcomes in patients receiving RFA for solitary small renal masses.
The authors reviewed the overall oncological and survival outcomes of patients with a solitary...
Authors: Levinson et al.
Suppressing growth and invasiveness of renal cancer cells by fatty acid synthase inhibitor
Sunday, 13 July 2008 - Fatty acid synthase has been shown to be over expressed in a wide range of cancers and it has emerged as a therapeutic target. Horiguchi et al. (2008) examined whether fatty acid synthase could be a novel...
Authors: Horiguchi et al.
Single Port Transumbilical (E-NOTES) Donor Nephrectomy
Friday, 11 July 2008 - Gill et al. (2008) present the initial 4 patients undergoing single port transumbilical live donor nephrectomy. Scar-free abdominal surgery via natural body orifices is called NOTES (natural orifice...
Authors: Gill et al.
Percutaneous and Laparoscopic Cryoablation of Small Renal Masses
Friday, 11 July 2008 - Finley et al. (2008) reviewed their 4-year experience with percutaneous cryoablation and laparoscopy for treating small renal masses.
After institutional review board approval the authors retrospectively...
Authors: Finley et al.
Evaluation of a homologous multi-epitope vaccine for renal cell carcinoma
Thursday, 10 July 2008 - In a recent phase-III trial, an adjuvant renal cell carcinoma (RCC) vaccine (Reniale) reduces the risk of tumour progression following nephrectomy. This clinical trial focused on efficacy and did not...
Authors: Doehn et al.
Endoluminal occlusion of inferior vena cava during radical nephrectomy and thrombectomy
Monday, 7 July 2008 - The surgical management of renal tumours with thrombi in the inferior vena cava (IVC) has become the gold standard treatment. Zini et al. (2008) evaluated endoluminal occlusion of the IVC during radical...
Authors: Zini et al.
Predicting disease progression after nephrectomy for localized renal cell carcinoma
Saturday, 5 July 2008 - Disease progression after nephrectomy for pathologically localized renal cell carcinoma (RCC) is associated with a significant mortality rate, given the limited efficacy of available treatment regimens for...
Authors: Crispen et al.
Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapy
Wednesday, 2 July 2008 - Renal cell carcinoma (RCC) is the third most common urologic neoplasm. This aggressive malignancy has proven refractory to conventional treatment options. Antiangiogenic agents have shown early success in...
Authors: Mellon et al.
Metastatic renal cell carcinoma: recent advances and current therapeutic options
Friday, 27 June 2008 - For many years immuno(chemo)therapy has been the only therapeutic option for patients with metastatic renal cell carcinoma. Recent advances in understanding the biology and genetics of this malignancy have...
Authors: Schrader et al.
Focal radiofrequency coagulation-assisted laparoscopic partial nephrectomy
Wednesday, 25 June 2008 - HABIB 4X™ is a laparoscopic focal radiofrequency-coagulation (FRFC) device utilized in liver and kidney resections to facilitate dissection while minimizing blood loss. Zeltser et al. (2008) evaluated...
Authors: Zeltser et al.
